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ABSTRACT 
Background: Airway clearance techniques (ACTs) are recommended for people with 
bronchiectasis both in stable state and during an acute exacerbation. Research has previously 
investigated ACTs for individuals in a stable state, but the safety and efficacy of ACTs during 
an acute exacerbation has not been reviewed.  
Methods: A systematic review was completed of studies of ACTs undertaken in adults and 
children experiencing an acute exacerbation of bronchiectasis. The databases Pubmed, 
Embase, PEDro and CINAHL were searched. Methodological quality of studies was 
examined using the modified Downs and Black tool. Key findings were synthesised using a 
critical narrative approach.  
Results: Six studies were included with a total of 120 participants. No eligible studies 
involving child participants were found. Overall, the methodological quality of studies was 
moderate. All ACTs investigated appeared safe for adults, with no adverse reactions reported. 
The active cycle of breathing technique may be more effective at improving gas exchange, 
sputum volume and health-related quality of life compared to postural drainage and 
percussion. Participants in two studies preferred oscillating positive expiratory pressure 
devices over the active cycle of breathing or postural drainage techniques.  
Conclusions: All airway clearance techniques reported in this review appeared safe for adults 
experiencing an acute exacerbation of bronchiectasis.  
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INTRODUCTION 
Bronchiectasis is a chronic and progressive lung condition which decreases health-related 
quality of life (HRQoL) (Barker, 2002; Mutalithas et al, 2008). Symptomatically, individuals 
have a chronic cough, sputum production, shortness of breath and decreased exercise 
tolerance (Goeminne and Dupont, 2010). Individuals suffer from recurrent lung infections 
which cause bronchial inflammation and permanent dilation, abnormal sputum clearance and 
bacterial colonisations which lead in turn to further infection (Barker, 2002; Flume, 
Chalmers, and Oliver, 2018; Goeminne and Dupont, 2010). Recurrent exacerbations lead to 
progressive deterioration of lung function and are one of the strongest predictors of 
morbidity, mortality and decreased HRQoL in bronchiectasis (Elborn and Bell, 2007; 
McShane, Naureckas, Tino, and Strek, 2013). 
An exacerbation of bronchiectasis is diagnosed when a clinician determines a change in 
bronchiectasis treatment is required as well as a deterioration in three or more of the 
following symptoms for at least forty-eight hours: cough; sputum volume and/or consistency; 
sputum purulence; haemoptysis, breathlessness and/or exercise tolerance; fatigue and/or 
malaise (Hill et al, 2017). The presentation of bronchiectasis, especially during an acute 
exacerbation, supports the prescription of airway clearance techniques (ACTs) as part of 
management alongside medical treatment such as oral or intravenous antibiotics and steroids 
(Chang et al, 2015; Pasteur, Bilton, Hill, and Group, 2010; Polverino et al, 2017). National 
and international guidelines recommend that physiotherapists should prescribe ACTs to 
individuals when experiencing an exacerbation and when stable (Chang et al, 2015; Pasteur et 
al, 2010; Polverino et al, 2017). It has been stated that ACTs are especially important during 
an exacerbation to clear the increased sputum load (Patterson et al, 2007). Airway clearance 
techniques may include breathing exercises such as the active cycle of breathing technique 
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(ACBT) and autogenic drainage, positioning and postural drainage (PD), manual techniques 
such as percussion or vibration, or techniques requiring a device such as positive expiratory 
pressure (PEP) therapy and oscillating PEP therapy (Snijders et al, 2015; van der Schans, 
2007). 
Previous reviews and research have focused on the use of ACTs during the stable clinical 
state of bronchiectasis, showing that various techniques such as PEP therapy, oscillating PEP 
therapy, PD, expiration with glottis open in lateral position (ETGOL) and high frequency 
chest wall oscillation are safe and effective at increasing sputum production compared to no 
intervention (Lee, Burge, and Holland, 2015; Lee, Williamson, Lorensini, and Spencer, 2015; 
Muñoz, Gracia, Buxó, Alvarez, and Vendrell, 2018). However, there is very limited evidence 
regarding the effectiveness of ACTs during an acute exacerbation of bronchiectasis that is not 
associated with cystic fibrosis. In the one previous review which included individuals 
experiencing an acute exacerbation as well as those in a stable state, the results did not 
separately analyse the findings based on clinical state and so the authors could only conclude 
that ACTs were safe for individuals during the stable state of their disease (Snijders et al, 
2015). There have been no systematic reviews investigating ACTs exclusively in individuals 
experiencing an acute exacerbation.  
The primary aim of this systematic review was therefore to establish if ACTs are safe for 
individuals experiencing an acute exacerbation of bronchiectasis not associated with cystic 
fibrosis. The secondary aim was to establish the effectiveness of ACTs in improving 
outcomes including sputum clearance, lung function, arterial blood gases, quality of life and 
breathlessness for these individuals. The protocol for this systematic review was registered 
with PROSPERO (PROSPERO 2016 CRD42016053306). 
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METHOD  
Guidance provided by the PRISMA statement for systematic reviews was followed for this 
systematic review (Moher, Liberati, Tetzlaff, Altman, and Group, 2009). Prior to conducting 
this review, the Cochrane Library, Physiotherapy Evidence Database (PEDro) and the 
PROSPERO database were searched to ensure a similar systematic review or protocol had 
not been published.  
Eligibility criteria 
Studies were eligible for inclusion if they included adults or children with a medical 
diagnosis of bronchiectasis not associated with cystic fibrosis (confirmed by HRCT scan, 
bronchography or physician) who were experiencing an acute exacerbation and who were 
prescribed ACT(s). Studies were excluded if they were not available in English or were 
published as abstract only, if they used a case study design or if interventions were completed 
without the goal of sputum clearance (e.g. mobility to increase exercise tolerance). Studies 
which involved multi-pronged interventions where the effects of each component could not 
be disentangled and studies which included individuals with a respiratory condition other 
than bronchiectasis were also excluded.  
Search strategy  
One investigator conducted the database search to identify studies that might be eligible for 
inclusion in the review. Electronic databases of Pubmed, Embase, PEDro and CINAHL were 
searched, as well as the grey literature database World Cat. Similar key words were used to 
search each database and included "bronchiectasis" AND "airway clearance techniques" OR 
"chest physiotherapy" OR "mucociliary clearance" OR "bronchopulmonary hygiene". 
Relevant synonyms of each term were also employed, as well as MeSH or other standardised 
terms used in each database. An example of the search strategy applied in PubMed and 
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adapted for other databases is included in Appendix 1. A manual search of the reference lists 
of included papers was also completed to identify any other studies of potential relevance. 
The search was completed in January 2018. No date, language or other filters were applied 
during the search.  
Study selection 
Two reviewers screened titles and abstracts of all articles identified in the search to exclude 
duplicates and all of those that were clearly ineligible. The full text of remaining articles was 
then reviewed by the same two reviewers, to assess eligibility for inclusion. A third reviewer 
was consulted if consensus could not be reached. Results of the search, screening and 
selection processes were documented in a PRISMA flow diagram (Moher et al, 2009).  
Quality assessment  
To assess the methodological quality of included articles, a modified Downs and Black 
critical appraisal tool (Downs and Black, 1998 ) was applied independently to each included 
article by two reviewers (JP and AL). The Downs and Black tool is a widely used, reliable 
and valid tool used to assess the methodological quality of both randomised and non-
randomised studies and contains items that assess methodological issues that may affect both 
internal and external validity. The original version of this tool has 27 questions that together 
score studies out of a total 32 points, as question 5 is scored on a 0-2-point scale and question 
27 on a 0-5 point scale. A modified version was used for this review, which scored both 
question 5 and question 27 dichotomously. Question 5 scored 1 if a list of principal 
confounders was reported and 0 if not, and question 27 scored 1 if a power or sample size 
calculation was attempted or reported and 0 if not. This modification has been used 
previously (Ng, Mackney, Jenkins, and Hill, 2012).  
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The quality of each included article was then rated using a scale from poor to strong quality, 
dependent on the total score. A percentage was calculated from the potential score out of 27. 
Articles were considered poor quality if scored <25%, limited quality if scored 25-49%, 
moderate quality if scored 50 – 74% and strong quality if scored >75% (Jäkel and von 
Hauenschild, 2011). No articles were excluded based on the quality assessment, but 
methodological quality of specific studies was considered during data synthesis and analysis.  
Data Extraction 
A standardised, pre-piloted form was used to extract data from each included study, including 
participant demographics, study setting, study methodology, interventions, outcome measures 
and timing of outcome measures. Missing data were requested from authors, where required, 
and extracted data were tabulated. If a paper also included participants with conditions other 
than an acute exacerbation of bronchiectasis not related to cystic fibrosis, only the 
participants experiencing an acute exacerbation of bronchiectasis were used in analysis for 
this review. 
Synthesis and outcomes  
A critical narrative approach was employed in the synthesis of key findings from included 
studies and was structured around the types of interventions investigated, target population 
characteristics, types of outcomes assessed and key findings. Criteria used to assess safety, 
acceptability and effectiveness of ACTs (clinical outcomes) are listed in Table 1 
(Venkategowda et al, 2014). Meta-analysis was not conducted due to the heterogeneity in 
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RESULTS  
The results from the search strategy and screening process can be seen in the PRISMA 
diagram in Figure 1. The search strategy yielded 3075 articles, of which 1085 were duplicates 
and excluded. A total of 1990 articles were screened by title and abstract and 54 remaining 
articles were screened in full text. There were six studies that met the eligibility criteria 
(Table 2).  
Quality assessment  
The final methodological quality scores assigned to each article by both reviewers can be 
seen in Table 3. There was excellent agreement between reviewers for the modified Downs 
and Black scores (98%, Kappa 0.95). The mean final score for the six studies was 18/27 
(range 14 – 24) (Table 3). Two studies were considered to be of strong methodological 
quality, and four of moderate quality. The overall mean score for all six studies represents a 
moderate methodological quality score. Most studies scored well for reporting and internal 
validity bias domains, and poorly for the external validity and confounding bias domains.  
Participants 
A total of 120 participants with an acute exacerbation of bronchiectasis were included in 
these six studies, of whom 62 (52%) were males (Table 2). Sample sizes ranged from two to 
30 participants, and all were adults. No studies were found that investigated children. Five of 
the six studies were completed in an inpatient setting, and one in an outpatient department. 
Table 2 provides further details of participant characteristics.  
Interventions 
Across the six included studies there were a range of interventions employed for airway 
clearance. Five studies compared the effects of two different techniques, and one study 
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investigated the impact of three different techniques. Overall, nine different techniques were 
included across the six studies; ACBT, PD +/- percussion, PEP devices, temporary positive 
expiratory pressure (TPEP), autogenic drainage, thoracic compression, oscillating PEP (using 
the Flutter® valve or Acapella® devices), and deep breathing exercises. Further details can be 
found in Table 2. 
Duration of the study periods across which ACT were administered to the participants varied 
greatly between studies, from one study including a single treatment session of each ACT 
(Herala and Gislason, 1988), to another study where the intervention was completed daily 
from hospital admission through to discharge (10 – 60 days) (D'Abrosca et al, 2017). The 
majority of studies ran for 6 to 14 days, which was the period of hospital admission or of 
antibiotic therapy.   
Prescription of ACTs each day and supervision of techniques being performed also varied 
amongst studies. One study completed in an outpatient setting had a physiotherapist teach an 
ACT (Acapella®) to participants on a single occasion at the start of an exacerbation, and then 
the participants were asked to complete it independently at home for the remainder of the 
study period (Patterson et al, 2007). Most participants in that study reported completing their 
prescribed ACT twice daily. The other five studies were implemented in an inpatient setting, 
where the ACT was supervised or performed (depending on the type of ACT) by a 
physiotherapist on each occasion. One study prescribed ACTs to be completed three times 
per day (Tsang and Jones, 2003), while two involved ACTs completed twice daily for the 
study period (AbdelHalim, AboElNaga, and Fathy, 2016; D'Abrosca et al, 2017). One study 
did not report how many times per day ACT were completed (Grillo et al, 2015), and the 
final study involved a single treatment session (Herala and Gislason, 1988). Table 2 provides 
further details.  
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Safety 
All six studies reported nil adverse events throughout their treatment routines (AbdelHalim et 
al, 2016; D'Abrosca et al, 2017; Grillo et al, 2015; Herala and Gislason, 1988; Patterson et al, 
2007; Tsang and Jones, 2003). However, one study did report some participants experienced 
occasional dizziness with PEP and TPEP due to hyperventilation (D'Abrosca et al, 2017). The 
authors did not report the number or percentage of participants that reported this side effect 
and the authors did not consider this an adverse event.  
In addition, the within-groups changes in clinical outcome measures reported in Table 4 
indicate that there were no instances where clinical or other patient outcomes were observed 
to significantly deteriorate over the course of treatment, with any of the treatment techniques. 
On this basis, there is no evidence from any of the included studies to indicate that any of the 
observed ACTs resulted in any harm to participants who were experiencing an acute 
exacerbation of bronchiectasis. 
Acceptability of technique  
Two studies examined acceptability to the participant of oscillating PEP (one using Acapella® 
device and the other using Flutter® device) and compared this to acceptability of “usual 
airway clearance” (90% ACBT, 10% PEP) or breathing and coughing in upright sitting or a 
PD position (Patterson et a., 2007; Tsang and Jones, 2003). Both showed participant 
preference towards oscillating PEP. The first study reported 7 of 10 participants preferred 
Acapella® to their “usual airway clearance technique” (majority using ACBT) and those 
participants chose to continue Acapella® as their ACT when reassessed one month following 
study cessation (Patterson et al, 2007). In the other study, Flutter® was consistently perceived 
to be more effective than breathing and coughing in upright sitting or a PD position, when 
effectiveness was measured by a subjective 4-point Likert scale ranging from “not effective 
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at all” to “very effective”, on day 2 and day 4 of hospital admission and on day of discharge, 
following an acute exacerbation (overall mean p = 0.011) (Tsang and Jones, 2003).  
Clinical Outcomes  
There were a variety of clinical and other patient outcomes assessed in participants with an 
acute exacerbation of bronchiectasis, including lung function, sputum clearance, arterial 
blood gases, quality of life and breathlessness. The key outcomes are presented below and 
further details are provided in Table 4. 
Sputum clearance 
Three studies reported the effects of ACTs on sputum clearance (AbdelHalim et al, 2016; 
Patterson et al, 2007; Tsang and Jones, 2003). The method by which sputum production or 
expectoration was measured varied through the studies, but most studies reported an 
improvement in sputum clearance following use of an ACT. Two studies implemented the 
ACBT and found improvements in sputum expectoration (wet weight or volume) over the 
course of an exacerbation (AbdelHalim et al, 2016; Patterson et al, 2007). Within one of 
those studies, the ACBT in a PD position was found to be superior to percussion in a PD 
position when completed twice per day over the course of 14 days and when the wet weight 
of sputum produced was measured at the beginning of an exacerbation and again on day 14 
(AbdelHalim et al, 2016). In the other study, use of the Acapella® was associated with a 
greater volume of sputum production in a single treatment session than “usual airway 
clearance technique” (90% ACBT, 10% PEP), but this difference did not reach statistical 
significance (Patterson et al, 2007). Both that study and one other found that oscillating PEP 
(Acapella® device or Flutter® device) improved sputum production when compared to “usual 
airway clearance therapy” (ACBT 90%, PEP 10%) or PD with breathing and coughing, but 
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this difference did not reach statistical significance (Patterson et al, 2007; Tsang and Jones, 
2003).  
Lung function 
Four of the six studies incorporated lung function tests using spirometry (forced expiratory 
volume in 1 second (FEV1), forced vital capacity (FVC), maximal mid-expiratory flow 
(MMEF), vital capacity (VC), peak expiratory flow (PEF)), pre and post an ACT 
(AbdelHalim et al., 2016; D'Abrosca et al., 2017; Patterson et al., 2007; Tsang and Jones, 
2003). In most studies, participants demonstrated a small but non-significant improvement in 
their lung function tests when the tests were administered at the beginning of an exacerbation 
and repeated following intervention or at the time of hospital discharge or cessation of 
antibiotics. However, none of the studies indicated that any given ACT was more effective 
than any other for improving lung function.  
Only one study found a small significant change in lung function test results when the tests 
were completed at the beginning of an exacerbation and again at cessation of antibiotic 
treatment which lasted 14 days. AbdelHalim et al. (2016) showed a significant improvement 
in FVC and MMEF following ACBT combined with PD administered twice daily for 14 
days. The same study also showed significant improvement in FEV1 and MMEF following 
percussion and PD completed twice per day for 14 days. However, despite these within-group 
improvements, there was no difference between the ACBT and percussion group in observed 
improvements (Table 4).  
Two studies conducted lung function testing before and after individual treatment sessions 
during the study period. One of these studies, comparing Acapella® to “usual airway 
clearance therapy” (ACBT 90%, PEP therapy 10%), found no changes in lung function after 
a single treatment session at the start or end of a course of oral antibiotics in either group, nor 
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a difference between groups in post-treatment lung function on either occasion (Patterson et 
al, 2007). The other study found similar results when comparing Flutter® valve, PD with 
breathing and coughing, and breathing and coughing in upright sitting, with no changes in 
lung function observed following treatment on day 2, day 4 or day of discharge within each 
ACT group (Tsang and Jones, 2003). Furthermore, no differences in lung function were 
observed between groups following treatment on any of those days (Tsang and Jones, 2003).  
Arterial blood gases and pulse oximetry 
Gas exchange measured by components of arterial blood gases (ABGs) was assessed as an 
outcome measure in two studies. AbdelHalim et al. (2016) showed gas exchange improved 
significantly following a course of treatment in hospital involving either ACBT with PD or 
percussion with PD. Following ACBT with PD, PaO2 and PAO2 both significantly improved, 
while following percussion with PD, PaCO2, PaO2 and PAO2 all improved significantly when 
compared to baseline. However, ACBT with PD was associated with superior improvement 
in PaO2 and in the P(A-a) O2 gradient when compared to percussion with PD. Another study 
found no difference in the changes in ABG results observed following use of TPEP and PEP 
(D'Abrosca et al, 2017).  
Pulse oximetry was measured in two studies, one during each treatment session and the other 
at the beginning and cessation of the study (Patterson et al, 2007; Tsang and Jones, 2003). 
Tsang and Jones (2003) reported no significant change in readings during treatment sessions 
involving Flutter® valve, PD with breathing and coughing, or breathing and coughing in 
upright sitting. The second study, which compared the observed changes in pulse oximetry 
readings following Acapella® to those following their “usual airway clearance therapy” 
(ACBT 90%, PEP 10%) reported no significant changes in either group from the beginning to 
the end of a course of oral antibiotics (Patterson et al, 2007). 
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One study measured blood gases using a transcutaneous electrode attached to the upper 
anterior chest during PEP therapy and thoracic compression (manual compression of the 
chest wall at end exhalation) (Herala and Gislason, 1988). Individual participant results were 
reported and two participants with an exacerbation of bronchiectasis were included in the 
study. Both participants experienced a small (0.1 and 1.5kPa) increase in transcutaneous 
pressure of oxygen with thoracic compression lasting 5 minutes or less. One participant 
experienced a small decrease in oxygen pressure with PEP therapy (-0.6 kPa) lasting 5 
minutes, whilst the other had an improvement of oxygen pressure with PEP therapy of 1.0kPa 
(Herala and Gislason, 1988). Both participants experienced a minimal decrease in the 
reported transcutaneous pressure of CO2 with both thoracic compression and PEP therapy, 
which lasted longer following thoracic compression compared to PEP therapy.  
Quality of Life, breathlessness and symptoms  
Only one study assessed quality of life, and they used the Leister Cough Questionnaire 
(AbdelHalim et al, 2016). This study found that although both groups showed improvement 
across the study period, ACBT with PD was superior to percussion with PD for improving 
cough-related quality of life over 14 days of treatment (p = 0.019).  
Two studies investigated breathlessness, using different outcome measures. One study used 
the BORG scale and the other the modified Medical Research Council (mMRC) scale. In one 
of these studies, breathlessness, as measured by the mMRC scale, was observed to 
significantly improve from beginning to end of hospital admission, which incorporated using 
either the ACBT with PD or percussion with PD (p < 0.001 and p < 0.001 respectively) 
(AbdelHalim et al, 2016). However, there was no significant difference between these 
techniques in the levels of improvement in breathlessness observed following their use 
(AbdelHalim et al, 2016). In the other study, which used the BORG breathlessness scale pre 
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and post intervention (on day 1 and on final day of oral antibiotics), no significant changes 
were observed in any of these measures (Patterson et al, 2007). This indicated that neither 
Acapella® nor “usual airway clearance therapy” (ACBT 90%, PEP 10%) changed patients’ 
perceived breathlessness in a single treatment session (Patterson et al, 2007).  
Only one study measured patient reported symptoms. Patterson et al. (2007) recorded 
patient’s respiratory symptoms across the course of an exacerbation, comparing symptoms in 
those using Acapella® with symptoms in those using “usual airway clearance therapy” 
(ACBT 90%, PEP 10%). Although participants within each treatment group improved 
following treatment on measures including sputum volume and colour, intensity and 
frequency of cough, fatigue, exercise tolerance, sinus discharge and appetite, there were no 
differences between the Acapella® and “usual airway clearance therapy” groups in observed 
improvements. 
Lung Clearance Index 
The lung clearance index was reported as an outcome in one study (Grillo et al, 2015). The 
lung clearance index was completed pre and post physiotherapy (ACBT with or without PD 
or autogenic drainage) at the start and end of an exacerbation (day of discharge). There was 
no significant difference on either occasion following physiotherapy (Grillo et al, 2015).  
DISCUSSION 
This is the first systematic review to have investigated ACTs exclusively in participants 
experiencing an acute exacerbation of bronchiectasis not associated with cystic fibrosis. It is 
noteworthy that no studies were found that included child participants; all six included 
studies involved adult participants experiencing an acute exacerbation. From these studies, a 
key finding is that a range of ACTs appeared to be safe to implement in adults experiencing 
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an acute exacerbation, as no studies reported any significant adverse events and none of the 
outcome measures reported in the studies deteriorated following use of the ACTs.  
Only one study found significant differences between two different types of ACTs. While 
both ACBT with PD and PD with percussion were associated with improved sputum 
expectoration, gas exchange and reduced dyspnoea, greater improvements in cough-related 
QoL, gas exchange and sputum expectoration were noted with ACBT with PD (AbdelHalim 
et al, 2016). This is similar to results found in other published systematic reviews, which state 
that ACBT may be superior to percussion and PD in short term sputum expectoration (Lewis, 
Williams, and Olds, 2012), and that percussion has shown limited effectiveness for sputum 
expectoration or improving lung function in patients with COPD or bronchiectasis (Holland, 
2014; van der Schans, 2007). It may also be because although a “huff” was taught to all 
participants in the ACBT group, it is unclear if participants in the percussion group were 
instructed to complete a “huff”, which may be one of the most important aspects of any ACT 
(van der Schans, 2007). These findings suggest that during an acute exacerbation of 
bronchiectasis, prescribing ACBT combined with percussion may improve sputum clearance, 
gas exchange and cough related QoL.  
While oscillating PEP appeared to show a trend in improved sputum expectoration in two 
studies, neither of these trends reached statistical significance (Patterson et al, 2007; Tsang 
and Jones, 2003). This may be due to low numbers of participants in the included studies or 
the heterogeneity in the control group (90% ACBT vs 10% PEP) (Patterson et al., 2007; 
Tsang and Jones, 2003). The timing of sputum collection was also variable, one study (Tsang 
and Jones, 2003) measured the sputum collected both during the treatment session and for the 
following 24 hours, whilst the other only collected sputum during the treatment session 
(Patterson et al, 2007). Sputum clearance may continue post completion of the ACT and so 
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this may be a limiting factor for why significance was not reached in the second study 
(Patterson et al, 2007). These findings correlate to findings in participants with stable 
bronchiectasis, where oscillating PEP was shown to be effective at increasing sputum 
clearance inconsistently amongst included studies (Lee, Williamson, et al, 2015).   
Two studies in this review highlighted that patients may prefer an oscillating PEP over ACBT 
+/- PD and breathing and coughing and felt that it may be more beneficial for sputum 
expectoration (Patterson et al, 2007; Tsang & Jones, 2003). It is widely recognised that 
patient preference and adherence to treatment in bronchiectasis is important (Chalmers, 
Aliberti, and Blasi, 2015; Pasteur et al, 2010; van der Schans, 2007). This may therefore 
require further consideration in future studies examining the comparisons of different types of 
ACTs during an exacerbation. Specifically, well powered studies which investigate 
oscillating PEP and ACBT during an acute exacerbation of bronchiectasis would be valuable. 
This is because from the studies conducted to date, these two techniques appear to be the 
most effective at improving patient outcomes, but from the current research it is unclear 
which is superior.  
A range of ACTs were examined across the six included studies. Within all the included 
studies, participants consistently demonstrated improvements (where measured) in sputum 
expectoration, lung function, cough related QoL and gas exchange, from beginning of an 
acute exacerbation to conclusion of the study. However, all studies applied ACTs within a 
multifaceted treatment regimen of antibiotics and other medical care. Based on this, the 
improvements seen from the beginning to the conclusion of each study indicate that while 
ACTs did not appear to cause a deterioration in a participants’ condition, the impact alone of 
an ACT and the extent of their contribution to observed effects on outcome measures is 
difficult to establish.  
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All included studies involved relatively small numbers of participants; these ranged from two 
to thirty participants. It is possible that potentially clinically significant findings were not 
identified due to low participant numbers decreasing the power of the studies. More studies 
involving larger participant cohorts are required to further develop knowledge in this area. As 
noted above, no studies were found by this review that investigated ACTs for children 
experiencing an acute exacerbation of bronchiectasis. There are specific factors that need to 
be considered prior to implementing ACT for children. These include age, complexity and 
demands of treatment, level of support, influences upon adherence and preserving family 
relationships and a child’s sense of normality (Lee, Button, and Tannenbaum, 2017). For 
these reasons, studies involving children are required. More studies with larger sample sizes 
are also needed to further ensure safety and assess adherence (Lee et al, 2017).  
Of the six included studies, two were found to be of strong methodological quality, and four 
of moderate methodological quality. Only one study made an attempt to blind those 
measuring the main outcome of the study, and to calculate the required sample size (Patterson 
et al, 2007). All studies recruited participants from the population of interest (adults 
experiencing an acute exacerbation of bronchiectasis) and participants in each group were 
recruited over the same period of time, where more than one group was involved. All studies 
also used accurate and valid outcome measures. It is common for studies in chronic 
respiratory disease patient populations to have low or moderate methodological quality, and 
so finding and including two studies that exhibited “strong” quality is a strength of this 
review (Jones and Rowe, 2000; Lee, Williamson, et al, 2015; Polverino et al, 2017). 
On this basis, further research into the safety and effectiveness of ACTs is required in 
participants experiencing an acute exacerbation of bronchiectasis, using larger sample sizes 
and with higher methodological quality. Future research should also consider a range of 
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ACTs, particularly those which are safe and effective when applied in people who are in a 
stable state of bronchiectasis such as PEP therapy and oscillating PEP therapy and ETGOL 
(Lee, Holland et al, 2015; Muñoz et al, 2018). This research is imperative as ACTs are 
currently recommended and routinely completed for patients with both stable bronchiectasis 
and during an acute exacerbation as per recommendations in clinical guidelines (Chalmers et 
al, 2015; Chang et al, 2015; O'Neill, Bradley, McArdle, and MacMahon, 2002; Pasteur et al, 
2010; Polverino et al, 2017) 
CONCLUSION  
Airway clearance techniques are routinely recommended by physicians as part of 
maintenance in patients with bronchiectasis, and guidelines suggest that a change of ACT 
may be required during an acute exacerbation (Chalmers et al, 2015; Pasteur et al, 2010). All 
ACTs implemented in the studies included in this review were reported to be well tolerated 
during an acute exacerbation. However, this review was limited by the small number of 
studies available and the fact that those included had limited sample sizes and involved only 
adults, and no children. The ACBT combined with PD was found to be superior in sputum 
expectoration, cough related quality of life and gas exchange when compared to percussion 
combined with PD. No other significant differences were observed in any of the included 
studies between specific ACTs, however oscillating PEP therapy was preferred by 
participants over other types of ACTs and may be associated with an increase in sputum 
production. More research is required with larger sample sizes and higher methodological 
quality, including both children as well as adult participants, to further assess the safety and 
effectiveness of ACTs in both adults and children experiencing an acute exacerbation of 
bronchiectasis.  
Disclosure of Interest: The authors report no conflict of interest. 
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Table 1: Criteria for assessing safety and effectiveness of ACTs  
Safety of ACT criteria: adverse reactions  Effectiveness of ACT criteria  
Negative change in pulmonary function 
tests 
Greater volume of sputum in a single 
treatment session 
Deterioration in patient reported symptoms Reduction in sputum volume across the 
course of treatment (e.g. 14 days of 
antibiotics)  
Decrease in blood oxygen levels measured 
by arterial blood gas or pulse oximetry by 
more than 5%* 
Positive change in blood oxygen levels 
measured by arterial blood gases or pulse 
oximetry 
 Improvement in patient reported symptoms 
 Improvement in HRQoL 
 Positive change in pulmonary function tests  
Key: ACT; Airway clearance technique; HRQoL; Health related quality of life  
*Venkategowda et al, 2001
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Table 2: Study Characteristics  
















28 13/15 41 – 














Blow through a 
mouthpiece keeping 
TPEP active as long as 
possible on every 
breath and cough as 
needed or at least every 
3-5 minutes.  
Two 15-minute sessions 
daily.  
Seated position with 
elbows resting on hard 
surface 
PEP mask: Instructed to 
reach and maintain the 
highest mid-expiratory 
pressure tolerated 
between 10 and 20cm 
H20 (measured by a 
manometer weekly), 
breathing at slightly 
increased Vt, but not to 
use force at the end of 
the expiration. Approx. 
every 2 minutes 
instructed to perform a 
FET manoeuvre; 




without the resistor. 
Two 15-minute sessions 
daily. 
Seated position with 
elbows resting on a hard 
surface 
AbdelHali
m et al. 
(2016) 














any outcome at 
baseline. 
mmRC p = 
0.897 
FVC p = 0.986 
FEV1 p = 
0.630 
Intervention: ACBT 
(breathing control, 2-3 
deep breaths, breathing 
control, huff), cough as 
required. 
Each cycle lasted 
approx. 2 minutes. 
Repeated 15-20 minutes 









Positions not reported. 






volume p = 
0.842 
ABGs p = 
0.140 – 0.330 
Nil significant 
difference in 










NR N/A Assessed by a 
physiotherapist at the 
start of treatment and 
prescribed an optimal 
technique which was 
completed until they 
had 2 clear cycles or 






ACBT +/- PD and 

















session on day one of 
ABs with a 
physiotherapist: 
2 postural drainage 
positions and 
Acapella® 
Maximum 15 minutes 
in each postural 
drainage position. 
Breathing control, 10 
breaths Acapella® 
inhaling to three-quarter 
maximum breathing 
capacity, 2-3 second 
breath hold, active 
exhalation to FRC, and 
30-minute training 
session on day 1 of oral 
ABs with a 
physiotherapist:  




and frequency of 
treatments. 
"Usual" was defined as 
the ACT currently used 
by the patient (no 
change made to their 
ACT). 90% of 
participants used 




a cough or huff in a set 
cycle. Completed twice 
daily  
Most patients 
completed the usual 



























first 24 hours 
of 
hospitalisation.  
PD: Adopt a maximum 
of 2 gravity dependent 
positions for drainage 
of secretions for total 
duration 15 mins. 
During the 15-minute 
session, patients were 
instructed to perform 
BC every 3 minutes - 
cycle of 5 slow deep 
breaths then one 
voluntary cough 
followed by normal 
relaxed breathing. 
FL: Taught the use of 
Flutter® in a sitting 
position for 15 minutes.  
Cycle every 3 minutes 
of 5 deep breaths 
expired through the 
Flutter®, then one cough 
followed by breathing 
control. Completed 
3x/day from day 2 of 
admission until DC 
BC: taught 
to perform 















from day 2 
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Completed 3x/day from 
day 2 of admission until 















NR N/A Thoracic Compression 
(TC): physiotherapist 
placed hands on lower 
part of thorax and 
manually compressed 
the thorax during the 
end of the exhalation. 
Completed 30 times at a 
comfortable rate in a 
sitting position. 
PEP - patients 
instructed to inhale and 
then to expire smoothly, 
without force through a 
plastic tube - the end of 
which was placed in a 
bottle containing 10cm 
of water. Completed 30 
times at a comfortable 
rate in a sitting position.   
 
Data are presented as mean (SD) of group as a whole or range of means (SD) if presented in multiple groups unless otherwise stated. 
Key: ABs: Antibiotics; ACBT: Active cycle of breathing technique; ACT; Airway clearance technique; AEB: Acute exacerbation of 
bronchiectasis; BC: Breathing and coughing; DC; Discharge; FET: Forced expiration technique; FL: Flutter® valve; FRC: Functional residual 
capacity; N/A: Not applicable; NI: Not included; NR: Not reported; PEP: Positive expiratory pressure; PD: Postural drainage; RCT: Randomised 
controlled trial; RXT: Crossover trial; TPEP: Temporary positive expiratory pressure; Vt: Tidal volume.  
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Table 3: Final quality assessment results  
Note: These are the final quality assessment scores yielded from assessment by two authors. Scores of 1 = Yes, 0 = No or unable to determine 
were used for each criterion. *A modified version was implemented, where question 5 and question 27 were each scored dichotomously.   
Studies = 6  Scores according to the modified* Downs and Black (1998) checklist  Quality 
Rating  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Total  
D'Abrosca 
et al. (2017)  
1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 15 Moderate 
AbdelHalim 
et al. (2016) 
1 1 1 1 1 1 0 1 1 1 0 0 1 0 0 1 1 1 0 1 1 1 1 0 1 1 0 19 Moderate 
Grillo et al. 
(2015) 
1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 1 1 1 1 1 1 0 0 1 1 0 15 Moderate 
Patterson et 
al. (2007) 








1 1 1 1 1 1 1 0 1 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 1 0 14 Moderate 
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Table 4: Summary of key findings  
Study Duration Outcome measures and timing  Summary of findings 
D'Abrosca et al. (2017)  Retrospective 
data from 4 years. 
Patients admitted 
for a minimum of 
10 days.  
Spirometry 
Arterial Blood gases 
All completed on admission and 
DC  
No significant difference between TPEP and PEP groups 
in spirometry (FVC p = 0.792, FEV1 p = 0.841) or 
arterial blood gases (pH p = 0.313, HCO3 p = 0.290, PO2 
p = 0.244, PCO2 p = 0.734).   
AbdelHalim et al. 
(2016) 
14 days  HRQoL - LCQ  
Dyspnoea - mMRC  
Spirometry  
Arterial blood gases 
Sputum collection (wet weight) 
daily  
All OCMs completed on admission 
and day 14 
Between groups differences: 
ACBT superior to control treatment in post 
physiotherapy outcome measures, as follows: 
• PaO2 (p = 0.043),  
• P(A-a) O2 gradient (p = 0.014)  
• LCQ physical score (p = 0.023)  
• LCQ total score (p = 0.019)  




ACBT group: last day of treatment compared to 
baseline: 
• Improvement in FVC (mean pre 70.69; post 
73.97; p < 0.001) and MMEF (p = 0.043).  
• Improvement in dyspnoea (mean pre 2.93; post 
1.6; p < 0.001) 
• Improvement in PaCO2 (mean pre 52.56; post 
47.02; p < 0.001),  
• Improvement in PaO2 (mean pre 73, post 80.86; p 
< 0.001) and PAO2 (mean pre 84.03, post 90.96; 
p < 0.001)  
• Improvement in sputum wet volume (pre 43 ml, 
post 14.67 ml; p < 0.001) 
• No change in FEV1 % predicted (p = 0.380), 
FEV1/FVC (p = 0.380) or P(A-a)O2 (p = 0.288) 
Control group: last day of treatment compared to 
baseline: 
• Improvement in FEV1 % predicted (pre 54.09, 
post 56.71; p = 0.044) and MMEF (pre 32.26, 
post 38.92; p < 0.001). 
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• Improvement in dyspnoea (pre 2.87, post 2; p < 
0.001) 
• Improvement in PaCO2 (pre 55.91, post 49.66; p 
= 0.002),  
• PaO2 (pre 60.67, post 69.13; p < 0.001) and 
PAO2 (pre 79.84, post 87.66; p = 0.002)  
• Improvement in sputum wet volume (pre 
43.67ml, post 19ml; p < 0.001). 
• No change in FVC (p = 0.705) or FEV1/FVC 
ratio (p = 0.101) or P(A-a)O2 ratio (p = 0.745). 
Grillo et al. (2015) NR Lung clearance index (LCI).  
Spirometry  
Completed on two occasions: visit 
1 within 48 hrs of admission; pre 
and post physiotherapy; and on 
reaching clinical recovery at DC as 
determined by a consultant pre and 
post physiotherapy  
 
No change in LCI from pre- to post-physiotherapy at 
visit 1 or on day of discharge (start exacerbation p = 
0.505; end exacerbation p = 0.491).   
Actual change in lung function tests not reported, all 
changes reported as z scores only. Small but significant 
change in FEV1 z score following physiotherapy at start 
and end exacerbation (start exacerbation p = 0.012; end 
exacerbation p = 0.037). 
34 
 
Patterson et al. (2007) 10-14 days 




Borg breathlessness scale 
(dyspnoea) 
15 count breathlessness score  
Questionnaire regarding patient’s 
perceived changes in sputum, 
cough and other symptoms.  
Number of coughs during session 
Completed pre and post ACT 
session day 1 and final day of oral 
ABs (day 10-14).  
  
No significant differences between groups in regards to 
any clinical outcomes.  
Spirometry: 
FEV1 (p = 0.13), FVC (p = 0.12) VC (p = 0.84) and PEF 
(p = 0.41) 
Sputum volume (p = 0.31), 
Patient perception of symptoms: 
Sputum volume (p = 0.91), Sputum colour (p = 0.19), 
intensity of cough (p = 0.97), frequency of cough (p = 
0.67), exercise tolerance (p = 0.17), fatigue (p = 0.69), 
sinus discharge (p = 0.06), appetite (p = 0.08).  
Breathlessness, SpO2, cough counts, p values not 
reported.  
Follow-up evaluation suggests Acapella® device may 




Tsang and Jones (2003) From day 2 of 
admission until 
DC  
PD: 7 days (3.3) 
FL: 6 days (3.83) 
BC: 5 days (0.84) 
Lung function assessed on day 1 
(before treatment) and then before 
and after each treatment session on 
days 2, 4 and day of DC.  
Wet weight of sputum: 
expectorated during the 15-minute 
session (S15), during the 15 mins 
after treatment (S30) and at 24 
hours (S24) - all recorded days 2 
and 4 and day of DC. 
HR and O2 saturations of patient 
monitored during each treatment. 
Patient questionnaire each session 
regarding perceived effectiveness 
and ease of application. 
FL subjectively, from patient questionnaire, significantly 
more effective than breathing control on each of the 
treatment days (day 2, p = 0.016, day 4, p = 0.013, day 
of DC, p = 0.013, overall p = 0.011).  
No significant difference between the scores on the 
patient questionnaire in the PD and FL groups reflecting 
subjective effectiveness (p values not reported). 
Neither PD or FL when combined with BC had any 
additional benefit over BC alone, as evidenced by no 
significant difference between groups regarding 
spirometry (FVC day 2, p = 0.069; day 4, p = 0.639; day 
D/C, p = 0.798: FEV1 day 2, p = 0.790; day 4, p = 0.302; 
day D/C, p = 0.843), sputum expectoration at any time 
point (p range 0.123 – 0.737), HR or SpO2 pre/post 
treatment at any time point (p value not reported).   
Herala and Gislason 
(1988) 
2 days – single 
treatment session 
each day.  
Transcutaneous partial pressure of 
PCO2 and PO2. Two electrodes 
attached with plastic mounting 
rings to the skin of the upper 
Small brief decrease in transcutaneous pressure of PCO2 
and small increase in transcutaneous pressure of PO2 in 
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anterior part of the thorax, in the 
mid subclavian region, after 
shaving and cleaning with alcohol. 
The electrodes were heated to 44 
degrees Celsius and physiotherapy 
commenced after at least 6 minutes 
of steady state. TcPCO2 and TcPO2 
monitored continuously.  
 
both thoracic compression and PEP treatment groups (p 
value not reported).  
 
Key: ABs: Antibiotics; ACBT: Active cycle of breathing technique; BC: Breathing and coughing; DC; Discharge; FEV1: Forced expiratory 
volume in 1 second % predicted; FL: Flutter® valve; FVC: Functional vital capacity (litres); HR: Heart Rate; HRQoL: Health related quality of 
life; LCI: Lung clearance index; LCQ: Leister Cough Questionnaire; MMEF: maximal mid-expiratory flow; mMRC: modified Medical Research 
Council; NR: Not reported; OCM: Outcome measures; PaO2: Partial pressure of Oxygen (mmHg); PaCO2: Partial pressure of Carbon dioxide 
(mmHg); PAO2: Partial pressure of alveolar oxygen (mmHg); PEP: Positive expiratory pressure; PD: Postural drainage; SpO2: pulse oximetry 
level (% haemoglobin saturated with oxygen); TcPCO2: Transcutaneous pressure of carbon dioxide (kPa); TcPO2: transcutaneous pressure of 
Oxygen (kPa); TPEP: Temporary positive expiratory pressure.  
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Appendix 1:  
Figure 1: PRISMA flow diagram depicting results of literature search and selection processes 
(CINAHL: Cumulative Index of Nursing and Allied Health Literature; PEDro: Physiotherapy 
Evidence Database)  
Studies included in 
the qualitative 
synthesis 
   
Records excluded 
based on title and 
abstract  






Records identified through 
database searching 



















n Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 1990) 
Records screened 
(n = 1990) 
Full-text articles 
assessed for eligibility 




(n = 48) 
 
No ACT completed: 4 
Stable patients: 34 
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Appendix 2:  
Search completed in PubMed:  
Bronchiectasis OR “primary ciliary dyskinesia” OR “young syndrome” OR “kartageners 




“respiratory therapy” OR “airway clearance” OR “airway clearance techniques” OR “airway 
clearance therapy” OR “chest physiotherapy” OR “chest physical therapy” OR “physical 
therapy” OR “mucociliary clearance” OR “bronchopulmonary hygiene” OR 
“tracheobronchial clearance” OR “active cycle” OR ACBT OR “deep breathing exercise” or 
DBE OR “thoracic expansion” OR TEE  OR “postural drainage” OR “gravity-assisted 
drainage” OR  “autogenic drainage” OR GAD OR FET OR “forced expiratory technique” 
OR  huff* OR  PEP OR PEEP OR “positive expiratory pressure” OR “hi PEP” OR “bubble-
PEP” OR “bottle-PEP” OR oscillat* OR “mouthpiece PEP” OR “pari-PEP” OR VRP1 OR 
flutter* OR desitin OR cornet OR acapella OR scandipharm OR percuss* OR vibrat* OR 
vest OR HFCWO OR OHFO  
 
PubMed MeSH Terms  
"Bronchiectasis"[MeSH]   
 "Kartagener Syndrome"[MeSH]  
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"Ciliary Motility Disorders"[MeSH] 




"Physical Therapy Modalities"[MeSH]  
"Mucociliary Clearance"[MeSH] 






Modified Downs and Black checklist used to determine methodological quality of included 
studies.  
Item Criteria Possible Answers 
Reporting 
1 Is the hypothesis/aim/objective of the study clearly described? Yes = 1 
No = 0 
 
2 
Are the main outcomes to be measured clearly described in the 
Introduction or Methods section? If the main outcomes are first 
mentioned in the Results section, the question should be 
answered no. 
 
Yes = 1 




Are the characteristics of the patients included in the study 
clearly described? In cohort studies and trials, inclusion and/or 
exclusion criteria should be given. In case-control studies, a 
case-definition and the source for controls should be given. 
 
Yes = 1 
No = 0 
 
4 
Are the interventions of interest clearly described? Treatments 
and placebo (where relevant) that are to be compared should be 
clearly described. 
Yes = 1 
No = 0 
 
5 
Are the distributions of principal confounders in each group of 
subjects to be compared clearly described? A list of principal 
confounders is provided. 
 
Yes = 1 
No = 0 
 
6 
Are the main findings of the study clearly described? Simple 
outcome data (including denominators and numerators) should 
be reported for all major findings so that the reader can check the 
major analyses and conclusions. (This question does not cover 
statistical tests which are considered below). 
 
Yes = 1 






Does the study provide estimates of the random variability in the 
data for the main outcomes? In non-normally distributed data the 
interquartile range of results should be reported. In normally 
distributed data the standard error, standard deviation or 
confidence intervals should be reported. If the distribution of the 
data is not described, it must be assumed that the estimates used 
were appropriate and the question should be answered yes. 
 
Yes = 1 
No = 0 
 
8 
Have all important adverse events that may be a consequence of 
the intervention been reported? This should be answered yes if 
the study demonstrates that there was a comprehensive attempt 
to measure adverse events. (A list of possible adverse events is 
provided). 
 
Yes = 1 




Have the characteristics of patients lost to follow-up been 
described? This should be answered yes where there were no 
losses to follow-up or where losses to follow-up were so small 
that findings would be unaffected by their inclusion. This should 
be answered no where a study does not report the number of 
patients lost to follow-up. 
 
Yes = 1 
No = 0 
 
10 
Have actual probability values been reported (e.g. 0.035 rather 
than <0.05) for the main outcomes except where the probability 
value is less than 0.001? 
Yes = 1 







Were the subjects asked to participate in the study representative 
of the entire population from which they were recruited? The 
study must identify the source population for patients and 
describe how the patients were selected. Patients would be 
representative if they comprised the entire source population, an 
unselected sample of consecutive patients, or a random sample. 
Random sampling is only feasible where a list of all members of 
the relevant population exists. Where a study does not report the 
proportion of the source population from which the patients are 




Yes = 1 
No = 0 







Were those subjects who were prepared to participate 
representative of the entire population from which they were 
recruited? The proportion of those asked who agreed should be 
stated. Validation that the sample was representative would 
include demonstrating that the distribution of the main 
confounding factors was the same in the study sample and the 
source population. 
 
Yes = 1 
No = 0 






Were the staff, places, and facilities where the patients were 
treated, representative of the treatment the majority of patients 
receive? For the question to be answered yes the study should 
demonstrate that the intervention was representative of that in 
use in the source population. The question should be answered 
no if, for example, the intervention was undertaken in a 
specialist centre unrepresentative of the hospitals most of the 
source population would attend. 
 
 
Yes = 1 
No = 0 
Unable to determine = 
0 
Internal validity - bias 
 
14 
Was an attempt made to blind study subjects to the intervention 
they have received? For studies where the patients would have 
no way of knowing which intervention they received, this should 
be answered yes. 
Yes = 1 
No = 0 




Was an attempt made to blind those measuring the main 
outcomes of the intervention? 
Yes = 1 
No = 0 




If any of the results of the study were based on “data dredging”, 
was this made clear? Any analyses that had not been planned at 
the outset of the study should be clearly indicated. If no 
retrospective unplanned subgroup analyses were reported, then 
answer yes. 
 
Yes = 1 
No = 0 






In trials and cohort studies, do the analyses adjust for different 
lengths of follow-up of patients, or in case-control studies, is the 
time period between the intervention and outcome the same for 
cases and controls? Where follow-up was the same for all study 
patients the answer should be yes. If different lengths of follow-
up were adjusted for by, for example, survival analysis the 
answer should be yes. Studies where differences in follow-up are 
ignored should be answered no. 
 
 
Yes = 1 
No = 0 








Were the statistical tests used to assess the main outcomes 
appropriate? The statistical techniques used must be appropriate 
to the data. For example, nonparametric methods should be used 
for small sample sizes. Where little statistical analysis has been 
undertaken but where there is no evidence of bias, the question 
should be answered yes. If the distribution of the data (normal or 
not) is not described it must be assumed that the estimates used 
were appropriate and the question should be answered yes. 
 
 
Yes = 1 
No = 0 





Was compliance with the intervention/s reliable? Where there 
was non- compliance with the allocated treatment or where there 
was contamination of one group, the question should be 
answered no. For studies where the effect of any 
misclassification was likely to bias any association to the null, 
the question should be answered yes. 
 
Yes = 1 
No = 0 




Were the main outcome measures used accurate (valid and 
reliable)? For studies where the outcome measures are clearly 
described, the question should be answered yes. For studies 
which refer to other work or that demonstrates the outcome 
measures are accurate, the question should be answered as yes. 
 
Yes = 1 
No = 0 
Unable to determine = 
0 
Internal validity - confounding (selection bias) 
 
21 
Were the patients in different intervention groups (trials and 
cohort studies) or were the cases and controls (case-control 
studies) recruited from the same population? For example, 
patients for all comparison groups should be selected from the 
same hospital. The question should be answered unable to 
determine for cohort and case-control studies where there is no 
information concerning the source of patients included in the 
study. 
 
Yes = 1 
No = 0 





Were study subjects in different intervention groups (trials and 
cohort studies) or were the cases and controls (case-control 
studies) recruited over the same period of time? For a study 
which does not specify the time period over which patients were 
recruited, the question should be answered as unable to 
determine. 
 
Yes = 1 
No = 0 




Were study subjects randomized to intervention groups? Studies 
which state that subjects were randomized should be answered 
yes except where method of randomization would not ensure 
random allocation. For example alternate allocation would score 
no because it is predictable. 
 
Yes = 1 
No = 0 







Was the randomized intervention assignment concealed from 
both patients and health care staff until recruitment was 
complete and irrevocable? All non- randomized studies should 
be answered no. If assignment was concealed from patients but 
not from staff, it should be answered no. 
 
Yes = 1 
No = 0 







Was there adequate adjustment for confounding in the analyses 
from which the main findings were drawn? This question should 
be answered no for trials if: the main conclusions of the study 
were based on analyses of treatment rather than intention to 
treat; the distribution of known confounders in the different 
treatment groups was not described; or the distribution of known 
confounders differed between the treatment groups but was not 
taken into account in the analyses. In non-randomized studies if 
the effect of the main confounders was not investigated or 
confounding was demonstrated but no adjustment was made in 




Yes = 1 
No = 0 




Were losses of patients to follow-up taken into account? If the 
numbers of patients lost to follow-up are not reported, the 
question should be answered as unable to determine. If the 
proportion lost to follow-up was too small to affect the main 
findings, the question should be answered yes. 
 
Yes = 1 
No = 0 





Did the study provide sample size calculations to determine 
appropriate power?  
Yes = 1 
No = 0 
 
 
